35 results
8-K
VIR
Vir Biotechnology Inc
13 Dec 23
Cost Associated with Exit or Disposal Activities
4:06pm
and patient impact. The Company is making purpose-led changes to align with its goals and ensure the Company is well-positioned for the future. These changes
8-K
EX-99.2
0cxp1p761
24 Feb 22
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:27pm
8-K
EX-99.1
4z5k6u lz
28 Jun 21
Other Events
6:07am
8-K
EX-99.2
cag64m80l nmh0i
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
EX-99.1
tqzdxbg8o1ini
13 Apr 21
Other Events
4:06pm
8-K
EX-99.1
gwm2hw20gg
16 Sep 20
Other Events
4:07pm
DEF 14A
pikkv6ar8502wr02
6 Apr 20
Definitive proxy
4:52pm